Matthijs D. Linssen

1.5k citations

21 papers · 792 indexed · h-index 14

Biomedical Engineering top 10%
Pulmonary and Respiratory Medicine top 10%
Surgery
Oncology
Biotechnology top 5%

Co-authors: Wouter B. Nagengast Gooitzen M. van Dam Annelies Jorritsma‐Smit Marjory Koller Vasilis Ntziachristos Dominic J. Robinson Steven J. de Jongh Bert van der Vegt
Topics: Photodynamic Therapy Research Studies (6 papers)Nanoplatforms for cancer theranostics (6 papers)Esophageal Cancer Research and Treatment (5 papers)
Cited by: Biotechnology Otorhinolaryngology Biomedical Engineering
Journals: Nature Communications Cancer Research Gut
Partner nations: Netherlands Germany China

In The Last Decade

Matthijs D. Linssen

20 papers receiving 791 citations

Peers

Countries citing papers authored by Matthijs D. Linssen

Since Specialization

Citations

This map shows the geographic impact of Matthijs D. Linssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthijs D. Linssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthijs D. Linssen more than expected).

Fields of papers citing papers by Matthijs D. Linssen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthijs D. Linssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthijs D. Linssen. The network helps show where Matthijs D. Linssen may publish in the future.

Co-authorship network of co-authors of Matthijs D. Linssen

This figure shows the co-authorship network connecting the top 25 collaborators of Matthijs D. Linssen. A scholar is included among the top collaborators of Matthijs D. Linssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthijs D. Linssen. Matthijs D. Linssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of Clinical-Grade Durvalumab-680LT and Nivolumab-800CW for Multispectral Fluorescent Imaging of the PD-1/PD-L1 Axis of the Immune Checkpoint Pathway 2025 ·Pharmaceuticals ·(unknown),(unknown),Matthijs D. Linssen,(unknown),(unknown),Bart G. J. Dekkers,Wouter B. Nagengast,Marjolijn N. Lub‐de Hooge	0
2	Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease 2024 ·Gut ·(unknown),(unknown),Matthijs D. Linssen,Michael Dobosz,(unknown),(unknown),Dominic J. Robinson,Marcela A. Hermoso,Marjolijn N. Lub–de Hooge,Eleonora A. Festen,Gürsah Kats‐Ugurlu,Gerard Dijkstra,Wouter B. Nagengast	7
3	EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial 2023 ·Nature Communications ·Jaron G. de Wit,Jasper Vonk,Floris J. Voskuil,Sebastiaan A. H. J. de Visscher,Kees‐Pieter Schepman,(unknown),Matthijs D. Linssen,Sjoerd G. Elias,György B. Halmos,Boudewijn E. C. Plaat,Jan J. Doff,Eben L. Rosenthal,Dominic J. Robinson,Bert van der Vegt,Wouter B. Nagengast,Gooitzen M. van Dam,Max J. H. Witjes	45
4	DOP15 Fluorescent labelled vedolizumab for real-time visualization and quantification of local drug distribution and pharmacodynamics in Inflammatory Bowel Diseases during endoscopy 2022 ·Journal of Crohn s and Colitis ·(unknown),Matthijs D. Linssen,(unknown),(unknown),(unknown),Gürsah Kats‐Ugurlu,(unknown),Gerard Dijkstra,Wouter B. Nagengast	1
5	Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy 2021 ·International Journal of Molecular Sciences ·Xiaojuan Zhao,Qingfeng Huang,Marjory Koller,Matthijs D. Linssen,(unknown),Steven J. de Jongh,Marcel A.T.M. van Vugt,Rudolf S.N. Fehrmann,En‐Min Li,Wouter B. Nagengast	5
6	Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW 2021 ·Scientific Reports ·(unknown),Pieter J. Steinkamp,Jan‐Luuk Hillebrands,Clark J. Zeebregts,Matthijs D. Linssen,Annelies Jorritsma‐Smit,Riemer H. J. A. Slart,Gooitzen M. van Dam,Hendrikus H. Boersma	8
7	Epidermal growth factor receptor targeted fluorescence molecular imaging for postoperative lymph node assessment in patients with oral cancer 2021 ·Journal of Nuclear Medicine ·Jasper Vonk,Jaron G. de Wit,Floris J. Voskuil,(unknown),(unknown),Matthijs D. Linssen,Evert van den Broek,Jan J. Doff,Sebastiaan A. H. J. de Visscher,(unknown),Bert van der Vegt,Gooitzen M. van Dam,(unknown)	16
8	Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial 2020 ·Journal of Nuclear Medicine ·Pieter J. Steinkamp,(unknown),Meifang Li,Matthijs D. Linssen,Floris J. Voskuil,Lukas B. Been,Barbara L. van Leeuwen,Albert J.H. Suurmeijer,Wouter B. Nagengast,Schelto Kruijff,Robert J. van Ginkel,Gooitzen M. van Dam	38
9	Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study 2020 ·Theranostics ·Floris J. Voskuil,Steven J. de Jongh,(unknown),Matthijs D. Linssen,Pieter J. Steinkamp,Sebastiaan A. H. J. de Visscher,Kees‐Pieter Schepman,Sjoerd G. Elias,(unknown),Pascal Jonker,Jan J. Doff,Annelies Jorritsma‐Smit,Wouter B. Nagengast,Bert van der Vegt,Dominic J. Robinson,Gooitzen M. van Dam,Max J. H. Witjes	71
10	Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer 2019 ·Gut ·Jolien J. Tjalma,Marjory Koller,Matthijs D. Linssen,Elmire Hartmans,(unknown),Annelies Jorritsma‐Smit,Arend Karrenbeld,Elisabeth G.E. de Vries,Jan H. Kleibeuker,Jan Pieter Pennings,Klaas Havenga,Patrick Hemmer,Geke A.P. Hospers,Boudewijn van Etten,Vasilis Ntziachristos,Gooitzen M. van Dam,Dominic J. Robinson,Wouter B. Nagengast	45
11	Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer 2019 ·Journal of Nuclear Medicine ·Steven J. de Jongh,Jolien J. Tjalma,Marjory Koller,Matthijs D. Linssen,Jasper Vonk,Michael Dobosz,Annelies Jorritsma‐Smit,Jan H. Kleibeuker,Geke A.P. Hospers,Klaas Havenga,Patrick Hemmer,Arend Karrenbeld,Gooitzen M. van Dam,Boudewijn van Etten,Wouter B. Nagengast	44
12	Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW 2019 ·Journal of Nuclear Medicine ·Matthijs D. Linssen,(unknown),(unknown),Marjolijn N. Lub–de Hooge,Gooitzen M. van Dam,Annelies Jorritsma‐Smit,Wouter B. Nagengast	26
13	Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers 2018 ·Nature Communications ·Marjory Koller,Siqi Qiu,Matthijs D. Linssen,Liesbeth Jansen,Wendy Kelder,Jakob de Vries,(unknown),Guo‐Jun Zhang,Dominic J. Robinson,Wouter B. Nagengast,Annelies Jorritsma‐Smit,Bert van der Vegt,Gooitzen M. van Dam	99
14	Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy 2018 ·Theranostics ·Elmire Hartmans,Jolien J. Tjalma,Matthijs D. Linssen,(unknown),Marjory Koller,Annelies Jorritsma‐Smit,(unknown),Sjoerd G. Elias,Arend Karrenbeld,Elisabeth G.E. de Vries,Jan H. Kleibeuker,Gooitzen M. van Dam,Dominic J. Robinson,Vasilis Ntziachristos,Wouter B. Nagengast	51
15	Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines 2017 ·Oncotarget ·Elmire Hartmans,Matthijs D. Linssen,(unknown),(unknown),Max J. H. Witjes,Gooitzen M. van Dam,Wouter B. Nagengast	13
16	Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A 2017 ·Gut ·Wouter B. Nagengast,Elmire Hartmans,P. Beatriz García-Allende,Frans Peters,Matthijs D. Linssen,Maximilian Koch,Marjory Koller,Jolien J. Tjalma,Arend Karrenbeld,Annelies Jorritsma‐Smit,Jan H. Kleibeuker,Gooitzen M. van Dam,Vasilis Ntziachristos	88
17	Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe 2017 ·Virulence ·(unknown),John M. Thompson,(unknown),(unknown),Carly Dillen,Roger V. Ortines,Alyssa G. Ashbaugh,Julie E. Pickett,Matthijs D. Linssen,Nicholas M. Bernthal,Kevin P. Francis,Girbe Buist,Marleen van Oosten,Gooitzen M. van Dam,Daniel L.J. Thorek,Lloyd Miller,Jan Maarten van Dijl	33
18	Abstract P4-01-01: Phase II in-human dose escalation study of the optical molecular imaging tracer bevacizumab-800cw for molecular fluorescence guided surgery in primary breast cancer patients 2017 ·Cancer Research ·(unknown),Marjory Koller,(unknown),Matthijs D. Linssen,J. de Vries,Liesbeth Jansen,Wendy Kelder,(unknown),Annelies Jorritsma‐Smit,Bert van der Vegt,DJ Robinson,(unknown)	3
19	Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study 2016 ·The Lancet. Gastroenterology & hepatology ·Niels J. Harlaar,Marjory Koller,Steven J. de Jongh,Barbara L. van Leeuwen,Patrick Hemmer,Schelto Kruijff,Robert J. van Ginkel,Lukas B. Been,Johannes S. de Jong,Gürsah Kats‐Ugurlu,Matthijs D. Linssen,Annelies Jorritsma‐Smit,Marleen van Oosten,Wouter B. Nagengast,Vasilis Ntziachristos,Gooitzen M. van Dam	145
20	Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use 2016 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown),Anton G.T. Terwisscha van Scheltinga,Matthijs D. Linssen,Wouter B. Nagengast,Ingo Lindner,Annelies Jorritsma‐Smit,Elisabeth G.E. de Vries,Jos G. W. Kosterink,Marjolijn N. Lub–de Hooge	48

About Matthijs D. Linssen

Matthijs D. Linssen is a scholar working on Otorhinolaryngology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 792 indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Esophageal Cancer Research and Treatment (5 papers). The work is most often cited by research in Biotechnology (131 citations), Otorhinolaryngology (63 citations) and Biomedical Engineering (387 citations). Matthijs D. Linssen has collaborated with scholars based in Netherlands, Germany and China. Frequent co-authors include Wouter B. Nagengast, Gooitzen M. van Dam, Annelies Jorritsma‐Smit, Marjory Koller, Vasilis Ntziachristos, Dominic J. Robinson, Steven J. de Jongh, Bert van der Vegt, Jolien J. Tjalma and Jan H. Kleibeuker. Their work appears in journals such as Nature Communications, Cancer Research and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact